在子选加速纳米载体设计,以实现高效的mRNA输送
Tristan Henser-Brownhill1, Liam Martin1, Parisa Samangouei1
1Nuntius Therapeutics Limited, London, W10 5JJ, UK.
概括
计算模型加速了用于mRNA疗法的脂质纳米载体的发现. 这种in silico选快速识别出高质量的候选人,降低了临床开发的成本和时间表.
科学领域:
- 生物技术和纳米医学
- 药物输送系统 药物输送系统
- 计算化学计算化学
背景情况:
- 脂质纳米载体对于提供核酸治疗药物至关重要.
- 对许多配方进行质量和效率的选是昂贵且耗时的.
- 开发有效的mRNA疗法需要高效的输送系统.
研究的目的:
- 开发用于预测纳米载体特性和mRNA递送效率的计算模型.
- 为了使大量潜在的纳米载体配方能够快速地进行in silico预选.
- 加速识别高质量的脂质纳米载体候选人用于mRNA疗法.
主要方法:
- 开发用于树脂分子-脂质纳米载体的预测计算模型.
- 物理化学性质预测和mRNA递送效率评估.
- 在超过450万个理论纳米载体配方的in silico选中.
- 通过基于细胞的测试,合成和验证最高预测的候选人.
主要成果:
- 成功开发和部署用于纳米载体查的计算模型.
- 通过in silico预测和实验验证,确定一种高质量,高性能的脂质纳米载体候选物.
- 展示快速,高吞吐量在中预选能力.
结论:
- 计算建模显著减少了与识别有效的脂质纳米载体用于mRNA输送相关的时间和成本.
- 开发的方法为加速基于mRNA的疗法的临床开发提供了强大的工具.
- 这种方法有可能简化新型核酸治疗药物的发现管道.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K


